Flavilium compounds and method of using

The invention relates to a compound of formula (I) (I) wherein X is a pharmacologically acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydro...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: TOTH, FERENC D, BORBELY, ILDIKO, BALINT, JANOS, KISS, JOLAN, SULYOK, GYOERGY
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator TOTH
FERENC D
BORBELY
ILDIKO
BALINT
JANOS
KISS
JOLAN
SULYOK
GYOERGY
description The invention relates to a compound of formula (I) (I) wherein X is a pharmacologically acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them. The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US5753695A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US5753695A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US5753695A3</originalsourceid><addsrcrecordid>eNrjZFB3y0ksy8zJLM1VSM7PLcgvzUspVkjMS1HITS3JyE9RyE9TKC3OzEvnYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxocGm5qbGZpamjsaEVQAADc4nWA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Flavilium compounds and method of using</title><source>esp@cenet</source><creator>TOTH; FERENC D ; BORBELY; ILDIKO ; BALINT; JANOS ; KISS; JOLAN ; SULYOK; GYOERGY</creator><creatorcontrib>TOTH; FERENC D ; BORBELY; ILDIKO ; BALINT; JANOS ; KISS; JOLAN ; SULYOK; GYOERGY</creatorcontrib><description>The invention relates to a compound of formula (I) (I) wherein X is a pharmacologically acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them. The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them.</description><edition>6</edition><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>1998</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19980519&amp;DB=EPODOC&amp;CC=US&amp;NR=5753695A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=19980519&amp;DB=EPODOC&amp;CC=US&amp;NR=5753695A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TOTH; FERENC D</creatorcontrib><creatorcontrib>BORBELY; ILDIKO</creatorcontrib><creatorcontrib>BALINT; JANOS</creatorcontrib><creatorcontrib>KISS; JOLAN</creatorcontrib><creatorcontrib>SULYOK; GYOERGY</creatorcontrib><title>Flavilium compounds and method of using</title><description>The invention relates to a compound of formula (I) (I) wherein X is a pharmacologically acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them. The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>1998</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFB3y0ksy8zJLM1VSM7PLcgvzUspVkjMS1HITS3JyE9RyE9TKC3OzEvnYWBNS8wpTuWF0twM8m6uIc4euqkF-fGpxQWJyal5qSXxocGm5qbGZpamjsaEVQAADc4nWA</recordid><startdate>19980519</startdate><enddate>19980519</enddate><creator>TOTH; FERENC D</creator><creator>BORBELY; ILDIKO</creator><creator>BALINT; JANOS</creator><creator>KISS; JOLAN</creator><creator>SULYOK; GYOERGY</creator><scope>EVB</scope></search><sort><creationdate>19980519</creationdate><title>Flavilium compounds and method of using</title><author>TOTH; FERENC D ; BORBELY; ILDIKO ; BALINT; JANOS ; KISS; JOLAN ; SULYOK; GYOERGY</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US5753695A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>1998</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>TOTH; FERENC D</creatorcontrib><creatorcontrib>BORBELY; ILDIKO</creatorcontrib><creatorcontrib>BALINT; JANOS</creatorcontrib><creatorcontrib>KISS; JOLAN</creatorcontrib><creatorcontrib>SULYOK; GYOERGY</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TOTH; FERENC D</au><au>BORBELY; ILDIKO</au><au>BALINT; JANOS</au><au>KISS; JOLAN</au><au>SULYOK; GYOERGY</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Flavilium compounds and method of using</title><date>1998-05-19</date><risdate>1998</risdate><abstract>The invention relates to a compound of formula (I) (I) wherein X is a pharmacologically acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them. The invention relates to a compound of formula (I) acceptable anion, R1 and R2 are independently of each other hydrogen, or an -OY group in which Y is hydrogen, an alpha -aminoacyl, or a C1-5 aminoalkyl residue, R3, R4 and R7 are independently of each other hydrogen, or a C1-5 alkyl residue R5 is hydrogen, and alpha -aminoacyl, or a C1-5 alkyl residue, and R6 is hydrogen, OH-, or a C1-5 alkyl residue, and pharmaceutically acceptable salts and esters thereof; and to condensation processes for preparing them.</abstract><edition>6</edition><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_US5753695A
source esp@cenet
subjects CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
title Flavilium compounds and method of using
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T16%3A13%3A38IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TOTH;%20FERENC%20D&rft.date=1998-05-19&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS5753695A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true